$MAS

Masco (NYSE:MAS) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

Masco Corp (NYSE:MAS) reported Q2 CY2026 sales of $1.99 billion, down 2.9% year on year and below Wall Street revenue estimates. Adjusted non-GAAP EPS was $1.64, up from $1.30 a year earlier and above analysts’ consensus. Full-year EPS guidance was expected to be roughly flat at $4.47 to $4.50, according to the article.

Original reporting
Published Jul 29, 2026, 12:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 12:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Masco (NYSE:MAS) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings — source image
Decision brief

The 30-second read

$MASNeutralMed
01

Why it matters

Q2 CY2026 shows a revenue decline and a miss versus estimates, but profitability improved with higher operating margin and adjusted EPS that beat consensus; full-year EPS is expected to stay roughly flat.

02

Market read

Traders can reassess near-term earnings durability versus top-line weakness using the provided revenue miss, margin expansion, and EPS outlook.

03

What to watch

The article does not quantify segment performance, backlog, or guidance details beyond EPS, which are key to judging whether the revenue decline is cyclical or structural.

Relevance 6/10Novelty 6/10Timing: after-hours or same-day reaction to Q2 CY2026 results and full-year EPS outlook

Background

Masco is a home-building design and manufacturing company (glass shower doors, lighting, bathtubs, faucets).

Company-level read

Ticker impact

$MASNeutralMedium confidence
Context

Masco reported Q2 CY2026 revenue of $1.99B, down 2.9% YoY, missing analyst expectations while adjusted EPS beat at $1.64.

Expected impact

Likely choppy trading, with downside risk if revenue weakness persists despite EPS outperformance.

Evidence & confidence

The article provides a concrete revenue miss versus estimates plus a beat on adjusted EPS and margin expansion, which can offset but not fully negate top-line concerns.

Market effects

Home-building products demand appears soft, reinforcing cautious read-through for residential construction-related industrials.

No specific regional demand signal provided beyond general home-building exposure.

No direct global macro or international exposure details disclosed.

Counterpoint

EPS outperformance may be driven by cost actions and buybacks rather than improving end-demand, so the revenue miss could reassert itself quickly.

Key entities

  • Masco Corporation

    Reported Q2 CY2026 revenue of $1.99B (down 2.9% YoY) and adjusted EPS of $1.64 (beat), with operating margin expansion.

  • Jon Nudi

    Masco President and CEO quoted saying the company executed well in the first half of the year.

Related articles

$MASHighAI 9/10

Masco (MAS) Q2 2026 Earnings Call Transcript

Masco’s Q2 2026 earnings call reported net tariff refund benefit of about $95 million for the quarter, partially offset by strategic investments and incentive costs. Net sales fell 3%. Operating profit rose 17% to $482 million, with operating margin 24.2% and EPS up 26% to $1.64. Masco raised 2026 EPS guidance to $4.40-$4.60 from $4.10-$4.30.

$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

$MASMedAI 8/10

Masco Boosts FY26 Outlook; Shares Surge 7.2% - Update

Masco Corp. (MAS) reported second-quarter results and raised its full-year 2026 guidance. It now expects FY26 earnings of $4.21 to $4.41 per share and adjusted earnings of $4.40 to $4.60 per share, versus prior ranges of $3.91 to $4.11 and $4.10 to $4.30. Shares were indicated lower in pre-market at about $75.70.

$MASMed

MASCO CORP /DE/ (MAS): Results of Operations and Financial Condition

MASCO CORP /DE/ (MAS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 a630268-kex99.htm EX-99 Document Exhibit 99 MASCO CORPORATION REPORTS SECOND QUARTER 2026 RESULTS Highlights • Net sales decreased 3 percent to $1,992 million • Operating profit margin was 23.6 percent; adjusted operating profit margin was 24.2 percent • Earnings per shar

$MASMed

Prime Kapital drops MAS share bid after rejecting selling prices

Prime Kapital, via PKMI, withdrew its offer to buy up to 30m MAS shares after reviewing bids submitted by July 3 and finding the offered prices “not sufficiently attractive,” so no clearing price was set and no shares were acquired. Prime Kapital already holds just over 61% of MAS and said its approach to MAS remains unchanged.